Health Care/Hospital
Lunit INSIGHT MMG, an AI Solution for Breast Cancer Detection, Now CE Certified
SEOUL, South Korea, June 2, 2020 /PRNewswire/ -- Lunit today announced that its AI solution for breast cancer, Lunit INSIGHT MMG, has been CE certified. The medical software was certified onMay 26th, making it now commercially available across the European Economic Area. The certified software, ...
icometrix launches its icompanion platform for people with multiple sclerosis
LEUVEN, Belgium and CHICAGO, June 2, 2020 /PRNewswire/ -- icometrix, the world leader to extract clinically meaningful data from brain scans, is proud to have launched the icompanion platform and phone application for people with multiple sclerosis on World MS Day! icompanion is a medical device...
Modular Bioscience Acquires Exclusive License to University of Illinois Urbana Champaign Artificial Restriction Enzyme Technology
SILICON VALLEY, Calif., June 2, 2020 /PRNewswire/ -- Modular Bioscience, an early stage biotechnology company based in Silicon Valley, today announced that it has executed a definitive agreement with theUniversity of Illinois at Urbana-Champaign for an exclusive global patent license to a novel a...
Adagio Medical Receives CE Mark Approval for its iCLAS(TM) Cryoablation System and Prepares for European Commercial Launch
LAGUNA HILLS, Calif., June 2, 2020 /PRNewswire/ -- Adagio Medical, Inc., announces that it has received CE Mark approval for its ultra-low temperaturei ntelligentContinuous Lesion Ablation System (iCLAS) for the endocardial treatment of paroxysmal (PAF) and persistent (PsAF) atrial fibrillation an...
icometrix launches its icompanion platform for people with multiple sclerosis
LEUVEN, Belgium and CHICAGO, June 2, 2020 /PRNewswire/ -- icometrix, the world leader to extract clinically meaningful data from brain scans, is proud to have launched the icompanion platform and phone application for people with multiple sclerosis on World MS Day! icompanion is a medical device...
Innovent Announced the Preliminary Results of the Anti-PD-1/PD-L1 Bispecific Antibody IBI318 in a Phase 1 Clinical Study
SUZHOU, China, June 2, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced the ...
AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings
AGC Biologics acquires Boulder, Colorado U.S.A. facility to increase global capacity and extend manufacturing scale SEATTLE, June 2, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the purchase of a state-of-the...
China Jo-Jo Drugstores Announces $10 Million Registered Direct Offering
HANGZHOU, China, June 1, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it ha...
Cynosure Launches Elite iQ™ Aesthetic Workstation For Laser Hair Removal and Skin Revitalization in the United States, Europe and Australia
The World's First Alexandrite-ND: YAG System Now Upgraded with Skintel®, The Industry's Only Melanin Reader™ For More Customized Laser Hair Removal Treatments For All Skin Types WESTFORD, Massachusetts, June 1, 2020 /PRNewswire/ -- Cynosure announced today the U.S., European and Australian launc...
Alchera exports a preventive solution of COVID-19 to San Pedro Square Market, San Jose
SEOUL, South Korea, June 1, 2020 /PRNewswire/ -- Alchera, the leading high-tech company inSouth Korea and a member company of the Born2Global Centre, with the specialty of Artificial Intelligence (AI) on the facial recognition technology, exported the preventive solution ofCOVID-19 to San Pedro S...
Luye Pharma Enters Distribution and Marketing Partnerships in South Korea, Hong Kong, and Thailand for Seroquel® and Seroquel XR®
SHANGHAI, June 1, 2020 /PRNewswire/ -- Luye Pharma Group (Luye Pharma) today held a special signing ceremony as part of the "We Care About Mental Health" initiative, marking the start of three new strategic partnerships across the region. As part of the initiative, Luye Pharma granted Alvogen Kor...
Henlius and Accord Receive Positive CHMP Opinion for Oncology Biosimilar, HLX02 (Trastuzumab)
SHANGHAI, June 1, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) and Accord Healthcare Limited (Accord) jointly announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing aut...
UOB intensifies COVID-19 safety measures by applying self-disinfecting coating at high-touch areas within its branches island-wide
SINGAPORE, June 1, 2020 /PRNewswire/ -- United Overseas Bank (UOB) today announced that it has enhanced the precautionary measures within its branches with the application of a commercial grade self-disinfecting coating at high-touch areas including branch counters and meeting areas. The initiati...
Uniview Temperature Screening Solutions Help Thailand Government to Fight Against COVID 19
BANGKOK, June 1, 2020 /PRNewswire/ -- In May, 2020, through the Ministry of Education, Ministry of Technology, and Prime Ministry's Office, Uniview provided enhanced temperature screening solutions and products, including CW-180, OET-213H-BTS1, and other Heat-Tracker series products, to help the ...
NCH Asia Pacific announces the specialized 'NCH Disinfection Program' to keep NCH customers' business running and protecting their customers
SINGAPORE, June 1, 2020 /PRNewswire/ -- NCH Asia Pacific, a global leader in industrial and commercial maintenance products and services since 1919, announced that it has launched a new'NCH Disinfection Program' to help businesses stay safe during the pandemic. COVID-19 haschanged lives and has ...
Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal
SYDNEY, June 1, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share a poster presentation of interim data from the ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most comm...
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)
SUZHOU, China, May 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announced ...
Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma
SUZHOU, China, May 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the research results of TY...
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
SUZHOU, China, May 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the results of TYVYT® (sin...
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)
SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announced ...
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00